Featured Bioprocessing Editorial
-
Here's What You Need To Know About The Access Consortium Pathway
11/20/2025
Five nations are collaborating on a work-sharing program to reduce regulatory duplication in drug development.
-
FDA Draft Guidance On CES Signals More Reliance On Toxicity And PK
11/19/2025
The technology to measure alternative metrics is vastly improved. Now, FDA joins other regulators in deprioritizing comparative efficacy studies for biosimilars.
-
Maximizing The Value Of An Internal Audit Program In Pharmaceutical Quality Operations
11/18/2025
A shrinking FDA and rising supply pressures demand stronger risk management and smarter internal audits. Here’s how pharma can truly “see things as they really are.”
-
AI Is Not The CMC Revolution You're Looking For, And That's OK
11/18/2025
Advanced therapy development today is less about big funding, more about frugality. Artificial intelligence unlocks a competitive advantage.
-
Phages As A Pharmaceutical: New EMA Guidance On Antimicrobial Drug Development
11/17/2025
The EMA has now issued a draft guidance on quality aspects of phage therapy medicinal products. Rising antimicrobial resistance has renewed interest in bacteriophages to fight pathogens.
-
How To Improve Sponsor–CMO Collaboration Around Digital Deviations
11/17/2025
Digital strategies and standardized data models cut manual work, boost accuracy and speed of information sharing, and build trust between sponsors and CMOs.
-
Solving The Stem Cell Consistency Conundrum With iMSCs
11/17/2025
The ability to produce unlimited batches of induced mesenchymal stem cells from a single iPSC cell bank is, perhaps, one of their most alluring features.
-
Sensitive Critical Starting Materials Need A 'Just-In-Data' Approach
11/14/2025
Here's a blueprint for transforming the fragmented, high-risk interface between vector and cell therapy platforms into a unified, predictable, and compliant system.
-
Exploring The Benefits Of Electroporation In NK Cell Transfection
11/14/2025
Electroporation creates temporary holes in cell membranes for genetic material to slip through. The technique offers some key advantages to viral transduction.
-
On The Potency Assurance Journey, Travelers Need A Road Map
11/13/2025
When regulatory expectations change by the phase, the route can be difficult and confusing to navigate for both new and experienced potency investigators.